7 Highest-Yielding Goldman Sachs Conviction List Stocks Can Thrive in a Recession24/7 Wall Street • 05/31/22
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced or Early-Stage Triple-Negative Breast Cancer at High Risk of RecurrenceBusiness Wire • 05/24/22
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete ResectionBusiness Wire • 05/20/22
While Inflation Surges Higher, 7 Warren Buffett Dividend Stocks Are Solid Safe Havens24/7 Wall Street • 05/12/22
Merck sees higher profit, sales for 2022 after strong 1Q driven by science unitMarket Watch • 05/12/22